Bortezomib and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors

This study has been completed.

Study NCT00027898 Information provided by National Cancer Institute (NCI)

First Received: December 7, 2001 Last Updated: May 12, 2009 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given

Publications:

Lieu C, Chow L, Pierson AS, Eckhardt SG, O'Bryant CL, Morrow M, Tran ZV, Wright JJ, Gore L. A phase I study of bortezomib, etoposide and carboplatin in patients with advanced solid tumors refractory to standard therapy. Invest New Drugs. 2009 Feb;27(1):53-62. Epub 2008 Jul 11.

Gore L, Witta S, Pierson AS, et al.: A phase I study of PS-341 (P), carboplatin (C), and etoposide (E) in patients (pts) with advanced solid tumors. [Abstract] Clin Cancer Res 9: A-C74, 6221s, 2003.